Cargando...
Activation of natural killer cells by rituximab in granulomatosis with polyangiitis
OBJECTIVE: In the last few years, anti-CD20 antibody rituximab profoundly changed the therapeutic landscape of granulomatosis with polyangiitis (GPA). Here, we investigated whether natural killer (NK) cells may play a role in rituximab’s mechanism of action in GPA. METHODS: B cell depletion, NK cell...
Guardado en:
| Publicado en: | Arthritis Res Ther |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6907269/ https://ncbi.nlm.nih.gov/pubmed/31829278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-2054-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|